Media Contact:
Stephen Majors
Vice President, Global Communications
smajors@alliancerm.org
Phoenix, AZ
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines, today announced the election of its 2025 Board of Directors.
Brussels, BE
The new EU Joint Clinical Assessment (JCA) will become an additional barrier for patient access to transformative advanced therapies if the HTA Coordination Group does not modernize its approach to evaluating these medicines, warned 30 not-for-profit organisations, including patient groups, scientific societies, research foundations and medical institutes, in a Call to Action.
San Diego, CA
This landmark partnership seeks to bolster efforts in aligning regulatory frameworks between the United States and Korea and jointly monitoring and reporting on trends within the field.
Brussels, BE
The EU Health Technology Assessment (HTA) Coordination Group’s ‘Methodological Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons’ is discouraging news for rare disease patients and the Advanced Therapy Medicinal Products (ATMP) sector.
